SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-608317
Filing Date
2016-05-31
Accepted
2016-05-31 16:06:06
Documents
3
Period of Report
2016-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d187935d8k.htm 8-K 15669
2 EX-10.1 d187935dex101.htm EX-10.1 728505
3 GRAPHIC g187935g29y16.jpg GRAPHIC 132318
  Complete submission text file 0001193125-16-608317.txt   927644
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 161685908
SIC: 2834 Pharmaceutical Preparations